Human medicines European public assessment report (EPAR): Nuceiva, botulinum toxin type a, Date of authorisation: 27/09/2019, Revision: 7, Status: Authorised

Submitted by Anonymous (not verified) on 28 May 2024 - 8:29

Human medicines European public assessment report (EPAR): Nuceiva, botulinum toxin type a, Date of authorisation: 27/09/2019, Revision: 7, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Vectormune FP ILT, Fowlpox and avian infectious laryngotracheitis vaccine (live, recombinant), Status: Authorised

Submitted by Anonymous (not verified) on 27 May 2024 - 13:36

Veterinary medicines European public assessment report (EPAR): Vectormune FP ILT, Fowlpox and avian infectious laryngotracheitis vaccine (live, recombinant), Status: Authorised

Human medicines European public assessment report (EPAR): Vyxeos liposomal (previously known as Vyxeos), daunorubicin,cytarabine, Date of authorisation: 23/08/2018, Revision: 10, Status: Authorised

Submitted by Anonymous (not verified) on 24 May 2024 - 16:00

Human medicines European public assessment report (EPAR): Vyxeos liposomal (previously known as Vyxeos), daunorubicin,cytarabine, Date of authorisation: 23/08/2018, Revision: 10, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness